about
Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule InhibitorVonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidenceDesign and implementation of a laboratory-based drug design and synthesis advanced pharmacy practice experienceLiver-stage malaria parasites vulnerable to diverse chemical scaffolds.Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese PopulationReview article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.Pharmaceutical principles of acid inhibitors: unmet needs.Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.Rabeprazole for the treatment of acid-related disorders.Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines.A receptor-grounded approach to teaching nonsteroidal antiinflammatory drug chemistry and structure-activity relationshipsCreation of medicinal chemistry learning communities through enhanced technology and interdisciplinary collaboration.Interaction between clopidogrel and proton-pump inhibitors.Science-based pharmacy education.Improving pharmacy students' understanding and long-term retention of acid-base chemistry.Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
P2860
Q27667046-27D97817-4357-4F57-A3D6-683C5DD24326Q28072552-0BF4FE47-FB17-425B-808B-A1286341DC14Q35596612-009DAF7A-E556-4548-813E-B416B83C316FQ36001246-2DAE0FC4-F360-47F7-9EF5-5325AF77546CQ36100105-E90011F1-3801-4DAA-8909-F08C940BE0F5Q37799470-13EF9540-6969-4486-A157-92DDDD22A8F1Q37957701-3C9C063D-8683-447E-B05F-EA96C61B1CEFQ38026988-CCB0A24E-B9D2-4AF7-AD52-2F43B56EE414Q38038691-A480E5D5-4A24-4795-B250-FC70B408B170Q38091317-758FF898-DE06-4F73-A1E3-D5A3CC654E61Q38237417-4B5F8049-AE9E-4574-AB20-1BF75DA73FF0Q38631128-E43FC475-CF90-44D5-9366-4123B1363CD7Q38958255-671BF104-1A64-4A7B-A620-DFD6DD176596Q39264038-58C3837F-322E-483D-B170-D6542190C552Q41829408-5E11794C-E2E2-480D-A571-230054A3D37FQ42723622-C45FF93D-8350-4693-A55F-725E865691A0Q42838729-958156FA-CC95-4DB5-B85B-E5EEBDA65448Q43118037-F1E3AB75-6656-4275-B183-1985A40E5AD2Q46203790-B730A514-50D4-498F-8766-ABED0CD76CD0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The chemically elegant proton pump inhibitors
@en
The chemically elegant proton pump inhibitors.
@nl
type
label
The chemically elegant proton pump inhibitors
@en
The chemically elegant proton pump inhibitors.
@nl
prefLabel
The chemically elegant proton pump inhibitors
@en
The chemically elegant proton pump inhibitors.
@nl
P2860
P356
P1476
The chemically elegant proton pump inhibitors
@en
P2093
Victoria F Roche
P2860
P356
10.5688/AJ7005101
P577
2006-10-01T00:00:00Z